Search Header Logo

Lecture 18 Vaccines part 1

Authored by Ana Maria Chamoun

Biology

University

DOK Level 3: Strategic Thinking covered

Used 4+ times

Lecture 18 Vaccines part 1
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

6 questions

Show all answers

1.

MULTIPLE SELECT QUESTION

45 sec • 2 pts

Which of the following are examples of a Jennerian vaccine? (Select all that apply)

vaccination with a live attenuated Mycobacterium bovis to prevent Mycobacterium tuberculosis in humans

vaccination with a viral vector encoding a protein of influenza virus

vaccination with cowpox virus to prevent smallpox in humans

vaccination with the varicella-zoster (chickenpox) live attenuated virus

2.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

When vaccinating against influenza by using a viral vector (e.g. adenovirus) that delivers an antigen of the influenza virus, one may also generate an immune response against the viral vector (e.g. adenovirus)?

True

False

3.

MULTIPLE SELECT QUESTION

45 sec • 2 pts

Which of the following would are most likely to be administered to a pregnant woman?

an mRNA vaccine (only introduces the mRNA that codes for the viral antigen)

live attenuated vaccine

killed or inactivated vaccine

a Jennerian vaccine

4.

MULTIPLE SELECT QUESTION

45 sec • 2 pts

Which of the following are disadvantages of using live-attenuated vaccines?

often results in long-term memory immunity

vaccine could revert to a virulent form and cause disease

cannot be administered to immunodeficient patients

induction of T and B cell immunity

5.

MULTIPLE SELECT QUESTION

45 sec • 1 pt

Which of the following can be used to generate an attenuated virus? (Select all that apply)

Monkey kidney cells

Embryonic chicken eggs

Human liver cells

Mouse skin cells

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Discuss the impact of viral mutations on vaccine development. How do these mutations challenge the effectiveness of existing vaccines?

Viral mutations have no impact on vaccine development.

Mutations can alter viral antigens, potentially reducing vaccine effectiveness and necessitating updates to vaccine formulations.

Mutations make viruses more susceptible to existing vaccines.

Mutations only occur in bacteria, not viruses.

Tags

DOK Level 3: Strategic Thinking

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?